Logo-bi

About Journal
BioImpacts   ISSN: 2228-5652 ; eISSN: 2228-5660
Where biological impacts are presented for biomedical and pharmaceutical scientists - Integrative Researches for Translational Medicines.
The BioImpacts (BI), which was founded by Prof. Y. Omidi in 2011, publishes timely, peer-reviewed papers on current topics important to biomedical/pharmaceutical scientists/researchers. BI issues, published every two months (six times a year) on a bimonthly basis (first day of January, March, May, July, September, November), cover a wide range of topics, including contemporary issues in biological (in vitro and in vivo) impacts of advanced and futuristic intervention at molecular, cellular, and in vivo dimensions. 

Journal Metrics

Article Types

Editorial; Reviews; Original research; Short communication; Spotlight; Perspective; Commentary; Lessons learned; Scientific analysis  Letter; Research education

Readership 
The journal's insights make it an attractive platform for professional multidisciplinary scientists such as cellular and molecular biologists, pharmacologists, biomedical technologist, pharmaceutical scientists, biological chemists, experimental biologists, geneticists, neuroscientists, biochemists, physiologists, biomedical researchers, translational scientists, and related clinicians.
Keywords
Integrative research, translational science, translational medicine, applied science, molecular biology, cell biology, genomics, and related omics technologies, systems biology, genetics, epigenetics, biomedicine, nanomedicine, molecular medicine, molecular therapy, gene and cell therapy, cell engineering, tissue engineering,  biotechnology, nanotechnology, synthetic biology, human biology, human genomics and proteomics, molecular pharmacology, herbal medicine, nanobiosensing and detection, science communication, public perception of science, bioscience education, bioethics, molecular imaging, biosimulation, bioinformatics.



As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge